|
|
|
|
| LEADER |
03607nam a2200361 u 4500 |
| 001 |
EB001872045 |
| 003 |
EBX01000000000000001035416 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
190824 r ||| eng |
| 020 |
|
|
|a 0309485258
|
| 020 |
|
|
|a 9780309485258
|
| 050 |
|
4 |
|a RA410.7
|
| 100 |
1 |
|
|a Addie, Siobhan
|
| 245 |
0 |
0 |
|a Understanding disparities in access to genomic medicine
|h Elektronische Ressource
|b proceedings of a workshop
|c Siobhan Addie, Joe Alper, and Sarah H. Beachy, rapporteurs ; Roundtable on Genomics and Precision Health, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
|
| 260 |
|
|
|a Washington, DC
|b The National Academies Press
|c 2018, [2018]©2018
|
| 300 |
|
|
|a xx, 105 pages
|b 1 color illustration
|c 23 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (pages 71-74)
|
| 505 |
0 |
|
|a Introduction and overview -- Exploring the barriers to accessing genomic and genetic services -- The role of health systems in delivering equitable access -- How can providers and payers make genomic medicine more accessible? -- Exploring innovative solutions and models of success -- Considering unmet needs to alleviate disparities in genomic medicine
|
| 653 |
|
|
|a Health Services Accessibility
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Genetic Services
|
| 653 |
|
|
|a Genomics
|
| 653 |
|
|
|a Healthcare Disparities
|
| 700 |
1 |
|
|a Alper, Joe
|e [rapporteur]
|
| 700 |
1 |
|
|a Beachy, Sarah H.
|e [rapporteur]
|
| 710 |
2 |
|
|a National Academies of Sciences, Engineering, and Medicine (U.S.)
|b Roundtable on Genomics and Precision Health
|
| 710 |
2 |
|
|a Understanding Disparities in Access to Genomic Medicine (Workshop) (2018, Washington, D.C.)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK533378
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a "Genomic medicine is defined as the routine use of genomic information about an individual as part of his or her clinical care as well as the health outcomes and policy implications of that clinical use. It is one approach that has the potential to improve the quality of health care by allowing practitioners to tailor prevention, diagnostic, and treatment strategies to individual patients. In recent years, research breakthroughs, technological advances, and the decreasing cost of DNA sequencing have led to the wider adoption of genomic medicine. However, as with the introduction of new technologies into health care, there are concerns that genetic and genomic testing and services will not reach all segments of the population both now and in the near future, and there remains a gap in knowledge regarding potential health care disparities in genomic medicine and precision health approaches. On June 27, 2018, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop to examine the gaps in knowledge related to access to genomic medicine and to discuss health care disparities and possible approaches to overcoming the disparate use of genomic medicine among populations. Workshop participants discussed research on access to genetics and genomics services in medically underserved areas, model programs of care for diverse patient populations, and current challenges and possible best practices for alleviating health care disparities as they relate to genomics-based approaches. This publication summarizes the presentations and discussions from the workshop."--Publisher's description
|